Global Molecular Diagnostics in Infectious Disease Testing Market Growth (Status and Outlook) 2024-2030

December 2024 | 108 pages | ID: GC991A7E693FEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Molecular Diagnostics in Infectious Disease Testing market size was valued at US$ million in 2023. With growing demand in downstream market, the Molecular Diagnostics in Infectious Disease Testing is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Molecular Diagnostics in Infectious Disease Testing market. Molecular Diagnostics in Infectious Disease Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Molecular Diagnostics in Infectious Disease Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Molecular Diagnostics in Infectious Disease Testing market.

Molecular diagnostics is a technique used to detect the presence of and identify genetic materials and proteins associated with specific health conditions and diseases, and infectious agents in body fluids such as blood, urine, or sputum. Molecular diagnostics for infectious disease testing is used by hospitals, academics institutions, laboratories, and others. Increasing number of infectious diseases and technological advancement in diagnostic technologies for infectious diseases are some major driving factors for molecular diagnostics in the infectious disease testing market. Molecular diagnostics technologies are mainly used to diagnose diseases such as AIDS, tuberculosis (TB), hepatitis, and hospital-acquired infections.

North America has the largest market for molecular diagnostics in infectious disease testing, followed by Europe. This is due to technological advancement in molecular diagnostic tools, increasing prevalence of infectious diseases and improved healthcare infrastructure in the region. The market in Asia too, is expected to witness a high growth rate in the next few years. This is due to evolving research and development activities on infectious diseases, increasing government support, growing awareness among people about various infectious diseases and their diagnostic procedures, and improving healthcare infrastructure in the region. In addition, growing population and economies in developing countries, such as India and China, are expected to influence the growth in molecular diagnostics in infectious disease testing in Asia.

Key Features:

The report on Molecular Diagnostics in Infectious Disease Testing market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Molecular Diagnostics in Infectious Disease Testing market. It may include historical data, market segmentation by Type (e.g., Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT)), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Molecular Diagnostics in Infectious Disease Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Molecular Diagnostics in Infectious Disease Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Molecular Diagnostics in Infectious Disease Testing industry. This include advancements in Molecular Diagnostics in Infectious Disease Testing technology, Molecular Diagnostics in Infectious Disease Testing new entrants, Molecular Diagnostics in Infectious Disease Testing new investment, and other innovations that are shaping the future of Molecular Diagnostics in Infectious Disease Testing.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Molecular Diagnostics in Infectious Disease Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Molecular Diagnostics in Infectious Disease Testing product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Molecular Diagnostics in Infectious Disease Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Molecular Diagnostics in Infectious Disease Testing market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Molecular Diagnostics in Infectious Disease Testing market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Molecular Diagnostics in Infectious Disease Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Molecular Diagnostics in Infectious Disease Testing market.

Market Segmentation:

Molecular Diagnostics in Infectious Disease Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type

• Polymerase Chain Reaction (PCR)
• Isothermal Nucleic Acid Amplification Technology (INAAT)
• Microarrays
• Next-Generation Sequencing (NGS)
• Hybridization
• Others

Segmentation by application

• Hospitals
• Clinics
• Academic Institutes
• Laboratories
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbott
• BD
• BioMerieux
• Thermo Fisher Scientific
• Roche
• Siemens
• Veridex
• Luminex
• GenMark Diagnostics
• Qiagen
• Genomix Biotech
• BioTheranostics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Molecular Diagnostics in Infectious Disease Testing Market Size 2019-2030
  2.1.2 Molecular Diagnostics in Infectious Disease Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Molecular Diagnostics in Infectious Disease Testing Segment by Type
  2.2.1 Polymerase Chain Reaction (PCR)
  2.2.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
  2.2.3 Microarrays
  2.2.4 Next-Generation Sequencing (NGS)
  2.2.5 Hybridization
  2.2.6 Others
2.3 Molecular Diagnostics in Infectious Disease Testing Market Size by Type
  2.3.1 Molecular Diagnostics in Infectious Disease Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type (2019-2024)
2.4 Molecular Diagnostics in Infectious Disease Testing Segment by Application
  2.4.1 Hospitals
  2.4.2 Clinics
  2.4.3 Academic Institutes
  2.4.4 Laboratories
  2.4.5 Others
2.5 Molecular Diagnostics in Infectious Disease Testing Market Size by Application
  2.5.1 Molecular Diagnostics in Infectious Disease Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Application (2019-2024)

3 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET SIZE BY PLAYER

3.1 Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Players
  3.1.1 Global Molecular Diagnostics in Infectious Disease Testing Revenue by Players (2019-2024)
  3.1.2 Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Players (2019-2024)
3.2 Global Molecular Diagnostics in Infectious Disease Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING BY REGIONS

4.1 Molecular Diagnostics in Infectious Disease Testing Market Size by Regions (2019-2024)
4.2 Americas Molecular Diagnostics in Infectious Disease Testing Market Size Growth (2019-2024)
4.3 APAC Molecular Diagnostics in Infectious Disease Testing Market Size Growth (2019-2024)
4.4 Europe Molecular Diagnostics in Infectious Disease Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2019-2024)
5.2 Americas Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2019-2024)
5.3 Americas Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2019-2024)
6.2 APAC Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2019-2024)
6.3 APAC Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Molecular Diagnostics in Infectious Disease Testing by Country (2019-2024)
7.2 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2019-2024)
7.3 Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing by Region (2019-2024)
8.2 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL MOLECULAR DIAGNOSTICS IN INFECTIOUS DISEASE TESTING MARKET FORECAST

10.1 Global Molecular Diagnostics in Infectious Disease Testing Forecast by Regions (2025-2030)
  10.1.1 Global Molecular Diagnostics in Infectious Disease Testing Forecast by Regions (2025-2030)
  10.1.2 Americas Molecular Diagnostics in Infectious Disease Testing Forecast
  10.1.3 APAC Molecular Diagnostics in Infectious Disease Testing Forecast
  10.1.4 Europe Molecular Diagnostics in Infectious Disease Testing Forecast
  10.1.5 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Forecast
10.2 Americas Molecular Diagnostics in Infectious Disease Testing Forecast by Country (2025-2030)
  10.2.1 United States Molecular Diagnostics in Infectious Disease Testing Market Forecast
  10.2.2 Canada Molecular Diagnostics in Infectious Disease Testing Market Forecast
  10.2.3 Mexico Molecular Diagnostics in Infectious Disease Testing Market Forecast
  10.2.4 Brazil Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.3 APAC Molecular Diagnostics in Infectious Disease Testing Forecast by Region (2025-2030)
  10.3.1 China Molecular Diagnostics in Infectious Disease Testing Market Forecast
  10.3.2 Japan Molecular Diagnostics in Infectious Disease Testing Market Forecast
  10.3.3 Korea Molecular Diagnostics in Infectious Disease Testing Market Forecast
  10.3.4 Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Forecast
  10.3.5 India Molecular Diagnostics in Infectious Disease Testing Market Forecast
  10.3.6 Australia Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.4 Europe Molecular Diagnostics in Infectious Disease Testing Forecast by Country (2025-2030)
  10.4.1 Germany Molecular Diagnostics in Infectious Disease Testing Market Forecast
  10.4.2 France Molecular Diagnostics in Infectious Disease Testing Market Forecast
  10.4.3 UK Molecular Diagnostics in Infectious Disease Testing Market Forecast
  10.4.4 Italy Molecular Diagnostics in Infectious Disease Testing Market Forecast
  10.4.5 Russia Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.5 Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Forecast by Region (2025-2030)
  10.5.1 Egypt Molecular Diagnostics in Infectious Disease Testing Market Forecast
  10.5.2 South Africa Molecular Diagnostics in Infectious Disease Testing Market Forecast
  10.5.3 Israel Molecular Diagnostics in Infectious Disease Testing Market Forecast
  10.5.4 Turkey Molecular Diagnostics in Infectious Disease Testing Market Forecast
  10.5.5 GCC Countries Molecular Diagnostics in Infectious Disease Testing Market Forecast
10.6 Global Molecular Diagnostics in Infectious Disease Testing Forecast by Type (2025-2030)
10.7 Global Molecular Diagnostics in Infectious Disease Testing Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Abbott
  11.1.1 Abbott Company Information
  11.1.2 Abbott Molecular Diagnostics in Infectious Disease Testing Product Offered
  11.1.3 Abbott Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Abbott Main Business Overview
  11.1.5 Abbott Latest Developments
11.2 BD
  11.2.1 BD Company Information
  11.2.2 BD Molecular Diagnostics in Infectious Disease Testing Product Offered
  11.2.3 BD Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 BD Main Business Overview
  11.2.5 BD Latest Developments
11.3 BioMerieux
  11.3.1 BioMerieux Company Information
  11.3.2 BioMerieux Molecular Diagnostics in Infectious Disease Testing Product Offered
  11.3.3 BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 BioMerieux Main Business Overview
  11.3.5 BioMerieux Latest Developments
11.4 Thermo Fisher Scientific
  11.4.1 Thermo Fisher Scientific Company Information
  11.4.2 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product Offered
  11.4.3 Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Thermo Fisher Scientific Main Business Overview
  11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Roche
  11.5.1 Roche Company Information
  11.5.2 Roche Molecular Diagnostics in Infectious Disease Testing Product Offered
  11.5.3 Roche Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Roche Main Business Overview
  11.5.5 Roche Latest Developments
11.6 Siemens
  11.6.1 Siemens Company Information
  11.6.2 Siemens Molecular Diagnostics in Infectious Disease Testing Product Offered
  11.6.3 Siemens Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Siemens Main Business Overview
  11.6.5 Siemens Latest Developments
11.7 Veridex
  11.7.1 Veridex Company Information
  11.7.2 Veridex Molecular Diagnostics in Infectious Disease Testing Product Offered
  11.7.3 Veridex Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Veridex Main Business Overview
  11.7.5 Veridex Latest Developments
11.8 Luminex
  11.8.1 Luminex Company Information
  11.8.2 Luminex Molecular Diagnostics in Infectious Disease Testing Product Offered
  11.8.3 Luminex Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Luminex Main Business Overview
  11.8.5 Luminex Latest Developments
11.9 GenMark Diagnostics
  11.9.1 GenMark Diagnostics Company Information
  11.9.2 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product Offered
  11.9.3 GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 GenMark Diagnostics Main Business Overview
  11.9.5 GenMark Diagnostics Latest Developments
11.10 Qiagen
  11.10.1 Qiagen Company Information
  11.10.2 Qiagen Molecular Diagnostics in Infectious Disease Testing Product Offered
  11.10.3 Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Qiagen Main Business Overview
  11.10.5 Qiagen Latest Developments
11.11 Genomix Biotech
  11.11.1 Genomix Biotech Company Information
  11.11.2 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product Offered
  11.11.3 Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Genomix Biotech Main Business Overview
  11.11.5 Genomix Biotech Latest Developments
11.12 BioTheranostics
  11.12.1 BioTheranostics Company Information
  11.12.2 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product Offered
  11.12.3 BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 BioTheranostics Main Business Overview
  11.12.5 BioTheranostics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Molecular Diagnostics in Infectious Disease Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Polymerase Chain Reaction (PCR)
Table 3. Major Players of Isothermal Nucleic Acid Amplification Technology (INAAT)
Table 4. Major Players of Microarrays
Table 5. Major Players of Next-Generation Sequencing (NGS)
Table 6. Major Players of Hybridization
Table 7. Major Players of Others
Table 8. Molecular Diagnostics in Infectious Disease Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 10. Global Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type (2019-2024)
Table 11. Molecular Diagnostics in Infectious Disease Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 12. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 13. Global Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Application (2019-2024)
Table 14. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Players (2019-2024) & ($ Millions)
Table 15. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Player (2019-2024)
Table 16. Molecular Diagnostics in Infectious Disease Testing Key Players Head office and Products Offered
Table 17. Molecular Diagnostics in Infectious Disease Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Molecular Diagnostics in Infectious Disease Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 21. Global Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Regions (2019-2024)
Table 22. Global Molecular Diagnostics in Infectious Disease Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 23. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Country/Region (2019-2024)
Table 24. Americas Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2019-2024) & ($ Millions)
Table 25. Americas Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Country (2019-2024)
Table 26. Americas Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 27. Americas Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type (2019-2024)
Table 28. Americas Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 29. Americas Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Application (2019-2024)
Table 30. APAC Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2019-2024) & ($ Millions)
Table 31. APAC Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Region (2019-2024)
Table 32. APAC Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 33. APAC Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type (2019-2024)
Table 34. APAC Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 35. APAC Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Application (2019-2024)
Table 36. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Country (2019-2024) & ($ Millions)
Table 37. Europe Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Country (2019-2024)
Table 38. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 39. Europe Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type (2019-2024)
Table 40. Europe Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 41. Europe Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Application (2019-2024)
Table 42. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Region (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Region (2019-2024)
Table 44. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Type (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type (2019-2024)
Table 46. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size by Application (2019-2024) & ($ Millions)
Table 47. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Application (2019-2024)
Table 48. Key Market Drivers & Growth Opportunities of Molecular Diagnostics in Infectious Disease Testing
Table 49. Key Market Challenges & Risks of Molecular Diagnostics in Infectious Disease Testing
Table 50. Key Industry Trends of Molecular Diagnostics in Infectious Disease Testing
Table 51. Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 52. Global Molecular Diagnostics in Infectious Disease Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 53. Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 54. Global Molecular Diagnostics in Infectious Disease Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 55. Abbott Details, Company Type, Molecular Diagnostics in Infectious Disease Testing Area Served and Its Competitors
Table 56. Abbott Molecular Diagnostics in Infectious Disease Testing Product Offered
Table 57. Abbott Molecular Diagnostics in Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Abbott Main Business
Table 59. Abbott Latest Developments
Table 60. BD Details, Company Type, Molecular Diagnostics in Infectious Disease Testing Area Served and Its Competitors
Table 61. BD Molecular Diagnostics in Infectious Disease Testing Product Offered
Table 62. BD Main Business
Table 63. BD Molecular Diagnostics in Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. BD Latest Developments
Table 65. BioMerieux Details, Company Type, Molecular Diagnostics in Infectious Disease Testing Area Served and Its Competitors
Table 66. BioMerieux Molecular Diagnostics in Infectious Disease Testing Product Offered
Table 67. BioMerieux Main Business
Table 68. BioMerieux Molecular Diagnostics in Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. BioMerieux Latest Developments
Table 70. Thermo Fisher Scientific Details, Company Type, Molecular Diagnostics in Infectious Disease Testing Area Served and Its Competitors
Table 71. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Product Offered
Table 72. Thermo Fisher Scientific Main Business
Table 73. Thermo Fisher Scientific Molecular Diagnostics in Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Thermo Fisher Scientific Latest Developments
Table 75. Roche Details, Company Type, Molecular Diagnostics in Infectious Disease Testing Area Served and Its Competitors
Table 76. Roche Molecular Diagnostics in Infectious Disease Testing Product Offered
Table 77. Roche Main Business
Table 78. Roche Molecular Diagnostics in Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Roche Latest Developments
Table 80. Siemens Details, Company Type, Molecular Diagnostics in Infectious Disease Testing Area Served and Its Competitors
Table 81. Siemens Molecular Diagnostics in Infectious Disease Testing Product Offered
Table 82. Siemens Main Business
Table 83. Siemens Molecular Diagnostics in Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Siemens Latest Developments
Table 85. Veridex Details, Company Type, Molecular Diagnostics in Infectious Disease Testing Area Served and Its Competitors
Table 86. Veridex Molecular Diagnostics in Infectious Disease Testing Product Offered
Table 87. Veridex Main Business
Table 88. Veridex Molecular Diagnostics in Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Veridex Latest Developments
Table 90. Luminex Details, Company Type, Molecular Diagnostics in Infectious Disease Testing Area Served and Its Competitors
Table 91. Luminex Molecular Diagnostics in Infectious Disease Testing Product Offered
Table 92. Luminex Main Business
Table 93. Luminex Molecular Diagnostics in Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Luminex Latest Developments
Table 95. GenMark Diagnostics Details, Company Type, Molecular Diagnostics in Infectious Disease Testing Area Served and Its Competitors
Table 96. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Product Offered
Table 97. GenMark Diagnostics Main Business
Table 98. GenMark Diagnostics Molecular Diagnostics in Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. GenMark Diagnostics Latest Developments
Table 100. Qiagen Details, Company Type, Molecular Diagnostics in Infectious Disease Testing Area Served and Its Competitors
Table 101. Qiagen Molecular Diagnostics in Infectious Disease Testing Product Offered
Table 102. Qiagen Main Business
Table 103. Qiagen Molecular Diagnostics in Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Qiagen Latest Developments
Table 105. Genomix Biotech Details, Company Type, Molecular Diagnostics in Infectious Disease Testing Area Served and Its Competitors
Table 106. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Product Offered
Table 107. Genomix Biotech Molecular Diagnostics in Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Genomix Biotech Main Business
Table 109. Genomix Biotech Latest Developments
Table 110. BioTheranostics Details, Company Type, Molecular Diagnostics in Infectious Disease Testing Area Served and Its Competitors
Table 111. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Product Offered
Table 112. BioTheranostics Main Business
Table 113. BioTheranostics Molecular Diagnostics in Infectious Disease Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. BioTheranostics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Molecular Diagnostics in Infectious Disease Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Molecular Diagnostics in Infectious Disease Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Molecular Diagnostics in Infectious Disease Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Country/Region (2023)
Figure 8. Molecular Diagnostics in Infectious Disease Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type in 2023
Figure 10. Molecular Diagnostics in Infectious Disease Testing in Hospitals
Figure 11. Global Molecular Diagnostics in Infectious Disease Testing Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Molecular Diagnostics in Infectious Disease Testing in Clinics
Figure 13. Global Molecular Diagnostics in Infectious Disease Testing Market: Clinics (2019-2024) & ($ Millions)
Figure 14. Molecular Diagnostics in Infectious Disease Testing in Academic Institutes
Figure 15. Global Molecular Diagnostics in Infectious Disease Testing Market: Academic Institutes (2019-2024) & ($ Millions)
Figure 16. Molecular Diagnostics in Infectious Disease Testing in Laboratories
Figure 17. Global Molecular Diagnostics in Infectious Disease Testing Market: Laboratories (2019-2024) & ($ Millions)
Figure 18. Molecular Diagnostics in Infectious Disease Testing in Others
Figure 19. Global Molecular Diagnostics in Infectious Disease Testing Market: Others (2019-2024) & ($ Millions)
Figure 20. Global Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Application in 2023
Figure 21. Global Molecular Diagnostics in Infectious Disease Testing Revenue Market Share by Player in 2023
Figure 22. Global Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Regions (2019-2024)
Figure 23. Americas Molecular Diagnostics in Infectious Disease Testing Market Size 2019-2024 ($ Millions)
Figure 24. APAC Molecular Diagnostics in Infectious Disease Testing Market Size 2019-2024 ($ Millions)
Figure 25. Europe Molecular Diagnostics in Infectious Disease Testing Market Size 2019-2024 ($ Millions)
Figure 26. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size 2019-2024 ($ Millions)
Figure 27. Americas Molecular Diagnostics in Infectious Disease Testing Value Market Share by Country in 2023
Figure 28. United States Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 29. Canada Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 30. Mexico Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 31. Brazil Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 32. APAC Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Region in 2023
Figure 33. APAC Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type in 2023
Figure 34. APAC Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Application in 2023
Figure 35. China Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 36. Japan Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 37. Korea Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 38. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. India Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 40. Australia Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 41. Europe Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Country in 2023
Figure 42. Europe Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type (2019-2024)
Figure 43. Europe Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Application (2019-2024)
Figure 44. Germany Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 45. France Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 46. UK Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. Italy Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 48. Russia Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 49. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size Market Share by Application (2019-2024)
Figure 52. Egypt Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 53. South Africa Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 54. Israel Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 55. Turkey Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 56. GCC Country Molecular Diagnostics in Infectious Disease Testing Market Size Growth 2019-2024 ($ Millions)
Figure 57. Americas Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 58. APAC Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 59. Europe Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 60. Middle East & Africa Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 61. United States Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 62. Canada Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 63. Mexico Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 64. Brazil Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 65. China Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 66. Japan Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 67. Korea Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 68. Southeast Asia Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 69. India Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 70. Australia Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 71. Germany Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 72. France Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 73. UK Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 74. Italy Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 75. Russia Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 76. Spain Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 77. Egypt Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 78. South Africa Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 79. Israel Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 80. Turkey Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 81. GCC Countries Molecular Diagnostics in Infectious Disease Testing Market Size 2025-2030 ($ Millions)
Figure 82. Global Molecular Diagnostics in Infectious Disease Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 83. Global Molecular Diagnostics in Infectious Disease Testing Market Size Market Share Forecast by Application (2025-2030)